This company has shut down. Bionter is no longer operating — its last tracked round was a Seed in 2022.
Explore the Startup GraveyardBionter operates as a company with the purpose of revolutionizing analytical testing for the benefit of people's health.
Bionter has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Bionter's investors include Dynamk Capital.
Bionter is headquartered in Riehen, Switzerland.
Bionter operates as a company with the purpose of revolutionizing analytical testing for the benefit of people's health.
Bionter is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bionter — Funding & Investors." VCBacked, April 27, 2022, https://www.vcbacked.co/company/bionter. Accessed August 14, 2026.
VCBacked. (2022). Bionter — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/bionter
{{cite web |title=Bionter — Funding & Investors |url=https://www.vcbacked.co/company/bionter |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated